Administrative Core
行政核心
基本信息
- 批准号:10487471
- 负责人:
- 金额:$ 65.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-06-24 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse effectsAdvisory CommitteesAnimalsApplications GrantsAreaArkansasCancer PatientCancer SurvivorCenters of Research ExcellenceCommunicationDisciplineDoctor of PhilosophyEnsureEnvironmentEvaluable DiseaseEvaluationFeesFundingGoalsGrantGrowthImmune responseInfrastructureInstitutionInterdisciplinary StudyIntestinesJournalsLifeMalignant NeoplasmsManuscriptsMedicalMentorsMethodsOccupational activity of managing financesOncologyPatientsPeer ReviewPersonsPhasePilot ProjectsProgram DevelopmentPublicationsQuality of lifeRadiation InjuriesResearchResearch PersonnelRoleScheduleScienceScientistSeriesServicesStructureSurvivorsTeacher Professional DevelopmentToxic effectToxicologyTranslational ResearchUniversitiesWritingcancer therapydesigndisabilityexperienceimprovedirradiationmeetingsmultidisciplinarynovel strategiesoperationpreventprogramsrecruitside effectsuccesssynergism
项目摘要
PROJECT SUMMARY/ABSTRACT
Many cancer patients and survivors suffer from adverse effects due to treatment that can arise both during
and after the completion of cancer therapy. The COBRE Center for Studies of Host Response to Cancer Therapy
supports investigators from various disciplines who 1) research the mechanisms by which cancer therapy causes
adverse effects, 2) identify new methods for detecting side effects sooner, and 3) develop novel strategies to
prevent or reduce side effects. The purpose of the Administrative Core (Core A) is to build a self-sustaining
research Center by maximizing opportunities for investigators to succeed and by promoting interactions and
synergy within the Center and with other research units in the institution. Core A will provide an efficient,
integrated administrative infrastructure for the COBRE Center (Aim 1), accelerate scientific growth through
faculty development and scientific advising (Aim 2), and expand and advance the Center toward self-
sustainability (Aim 3). A primary function of the core is to provide administrative support for project leaders and
to manage financial affairs for the Center as a whole. Core A ensures there is effective communication within
and among the projects and cores. Additionally, the core provides the infrastructure for scientific advising and
faculty development, which will encourage scientific progress for project leaders and will help integrate their
efforts with those of other scientists on campus. With assistance of the External Advisory Committee, new project
leaders will be recruited and selected to replace those who graduate from COBRE advisee status. The Center
also will perform a systematic, objective evaluation of activities, project leaders and their research, scientific
advising and faculty development programs, and core functions. This strategy will ensure the long-term success
of the Center as an independent but well-integrated investigative unit on campus with a vibrant and synergistic
research environment that comprehensively addresses the short-term and long-term side effects of cancer
therapy.
项目摘要/摘要
许多癌症患者和幸存者由于在两种情况下可能出现的治疗而遭受不良反应
并在癌症治疗完成后。科布雷癌症治疗宿主反应研究中心
支持来自不同学科的研究人员,他们1)研究癌症治疗引起的机制
不良反应,2)更快地确定检测副作用的新方法,以及3)开发新的战略,以
预防或减少副作用。行政核心(核心A)的目的是建立一个自我维持的
通过最大限度地增加研究人员的成功机会并通过促进互动和
中心内部以及与机构内其他研究单位的协同作用。核心A将提供高效、
科布雷中心的综合行政基础设施(目标1),通过
教师发展和科学咨询(目标2),并扩大和推进中心走向自我
可持续性(目标3)。核心的一个主要职能是为项目负责人和
负责中心的整体财务管理工作。核心A确保内部有效沟通
在这些项目和核心中。此外,该核心还为科学咨询和
教师发展,这将鼓励项目负责人的科学进步,并将有助于整合他们的
与校园里的其他科学家一起努力。在外部咨询委员会的协助下,新项目
将招聘和挑选领导人,以取代那些从科布雷顾问身份毕业的人。《中心》
还将对活动、项目负责人及其研究、科学进行系统、客观的评价
咨询和教师发展计划,以及核心职能。这一战略将确保长期的成功。
该中心是一个独立但整合良好的校园调查单位,具有活力和协同性
全面解决癌症短期和长期副作用的研究环境
心理治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marjan Boerma其他文献
Marjan Boerma的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marjan Boerma', 18)}}的其他基金
Development of a minimally invasive biomarker assay to detect delayed radiation injury
开发微创生物标志物检测来检测迟发性辐射损伤
- 批准号:
10515695 - 财政年份:2020
- 资助金额:
$ 65.43万 - 项目类别:
Development of a minimally invasive biomarker assay to detect delayed radiation injury
开发微创生物标志物检测来检测迟发性辐射损伤
- 批准号:
10336587 - 财政年份:2020
- 资助金额:
$ 65.43万 - 项目类别:
Development of a minimally invasive biomarker assay to detect delayed radiation injury
开发微创生物标志物检测来检测迟发性辐射损伤
- 批准号:
10728721 - 财政年份:2020
- 资助金额:
$ 65.43万 - 项目类别:
Development of a minimally invasive biomarker assay to detect delayed radiation injury
开发微创生物标志物检测来检测迟发性辐射损伤
- 批准号:
10546448 - 财政年份:2020
- 资助金额:
$ 65.43万 - 项目类别:
Development of a minimally invasive biomarker assay to detect delayed radiation injury
开发微创生物标志物检测来检测迟发性辐射损伤
- 批准号:
10090564 - 财政年份:2020
- 资助金额:
$ 65.43万 - 项目类别:
Development of a minimally invasive biomarker assay to detect delayed radiation injury
开发微创生物标志物检测来检测迟发性辐射损伤
- 批准号:
10339340 - 财政年份:2020
- 资助金额:
$ 65.43万 - 项目类别:
The Protein C Pathway in Mitigation of Radiation-Induced Endothelial and Vascular Dysfunction
减轻辐射引起的内皮和血管功能障碍的蛋白 C 途径
- 批准号:
9384928 - 财政年份:2017
- 资助金额:
$ 65.43万 - 项目类别:
The Protein C Pathway in Mitigation of Radiation-Induced Endothelial and Vascular Dysfunction
减轻辐射引起的内皮和血管功能障碍的蛋白 C 途径
- 批准号:
10179310 - 财政年份:2017
- 资助金额:
$ 65.43万 - 项目类别:
Center for Studies of Host Response to Cancer Therapy
宿主对癌症治疗的反应研究中心
- 批准号:
10667643 - 财政年份:2015
- 资助金额:
$ 65.43万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 65.43万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 65.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 65.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 65.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 65.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 65.43万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 65.43万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 65.43万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 65.43万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 65.43万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




